Open AccessNew National Cholesterol Education Program III Guidelines for Primary Prevention Lipid-Lowering Drug Therapy
Author(s) -
Donald O. Fedder,
Carol E. Koro,
Gilbert L’Italien
Publication year - 2002
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/hc0202.101971
Subject(s) - medicine , national health and nutrition examination survey , national cholesterol education program , population , cholesterol , demography , environmental health , obesity , metabolic syndrome , sociology
The guidelines in the Third Report of the National Cholesterol Education Program (NCEP III) include absolute risk and lower LDL cholesterol (LDL-C) levels to assess eligibility for lipid-lowering drug therapy. We studied the impact of these changes on the size, sex, and age distribution of the target US population using data from the Third Annual National Health and Nutrition Survey (NHANES III) (1988 to 1994).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom